362 related articles for article (PubMed ID: 32456226)
1. Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications.
Jin W
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32456226
[TBL] [Abstract][Full Text] [Related]
2. Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned so Far.
Martellucci S; Clementi L; Sabetta S; Mattei V; Botta L; Angelucci A
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32498343
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
[TBL] [Abstract][Full Text] [Related]
4. Src, chemoresistance and epithelial to mesenchymal transition: are they related?
Shah AN; Gallick GE
Anticancer Drugs; 2007 Apr; 18(4):371-5. PubMed ID: 17351389
[TBL] [Abstract][Full Text] [Related]
5. Claudin-1 promotes TNF-α-induced epithelial-mesenchymal transition and migration in colorectal adenocarcinoma cells.
Bhat AA; Ahmad R; Uppada SB; Singh AB; Dhawan P
Exp Cell Res; 2016 Nov; 349(1):119-127. PubMed ID: 27742576
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer.
Sirvent A; Benistant C; Roche S
Am J Cancer Res; 2012; 2(4):357-71. PubMed ID: 22860228
[TBL] [Abstract][Full Text] [Related]
7. High Glucose Concentrations Negatively Regulate the IGF1R/Src/ERK Axis through the MicroRNA-9 in Colorectal Cancer.
Chen YC; Ou MC; Fang CW; Lee TH; Tzeng SL
Cells; 2019 Apr; 8(4):. PubMed ID: 30965609
[TBL] [Abstract][Full Text] [Related]
8. Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis.
Patel A; Sabbineni H; Clarke A; Somanath PR
Life Sci; 2016 Jul; 157():52-61. PubMed ID: 27245276
[TBL] [Abstract][Full Text] [Related]
9. The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets.
Liu W; Kovacevic Z; Peng Z; Jin R; Wang P; Yue F; Zheng M; Huang ML; Jansson PJ; Richardson V; Kalinowski DS; Lane DJ; Merlot AM; Sahni S; Richardson DR
Oncotarget; 2015 Nov; 6(34):35522-41. PubMed ID: 26431493
[TBL] [Abstract][Full Text] [Related]
10. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
11. TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK/Src and ERK pathways.
Wang Y; Wu N; Pang B; Tong D; Sun D; Sun H; Zhang C; Sun W; Meng X; Bai J; Chen F; Geng J; Fu S; Jin Y
Oncotarget; 2017 Jul; 8(29):47931-47942. PubMed ID: 28624785
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of Src family kinases and therapeutic implications of their modulators.
Kumar A; Jaggi AS; Singh N
Fundam Clin Pharmacol; 2015 Apr; 29(2):115-30. PubMed ID: 25545125
[TBL] [Abstract][Full Text] [Related]
13. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
14. Src Family Kinases Regulate Interferon Regulatory Factor 1 K63 Ubiquitination following Activation by TLR7/8 Vaccine Adjuvant in Human Monocytes and B Cells.
Tulli L; Cattaneo F; Vinot J; Baldari CT; D'Oro U
Front Immunol; 2018; 9():330. PubMed ID: 29545793
[TBL] [Abstract][Full Text] [Related]
15. Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: implications for disease-associated kinases.
Cheng HC; Johnson TM; Mills RD; Chong YP; Chan KC; Culvenor JG
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):93-101. PubMed ID: 19566834
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway.
Lu D; Yao Q; Zhan C; Le-Meng Z; Liu H; Cai Y; Tu C; Li X; Zou Y; Zhang S
Oncotarget; 2017 Apr; 8(14):22674-22684. PubMed ID: 28186967
[TBL] [Abstract][Full Text] [Related]
18. SRC family kinases: potential targets for the treatment of human cancer and leukemia.
Warmuth M; Damoiseaux R; Liu Y; Fabbro D; Gray N
Curr Pharm Des; 2003; 9(25):2043-59. PubMed ID: 14529415
[TBL] [Abstract][Full Text] [Related]
19. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
[No Abstract] [Full Text] [Related]
[Next] [New Search]